Febuxostat
NDC 0054-0413, Febuxostat, tablet, from Hikma Pharmaceuticals USA Inc.
- Product NDC
- 0054-0413
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205414
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEBUXOSTAT40 mg/1
Pharmacologic classes
Xanthine Oxidase Inhibitor [EPC]; Xanthine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0054-0413-13 | 00054041313 | 30 TABLET in 1 BOTTLE (0054-0413-13) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/14f1555c-2565-42c7-b3f5-dd5f03fed67aNADAC price for package 00054041313
GET /v1/drugs/nadac/00054041313
Use it
Look up 0054-0413 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0054-0413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.